PCR method to simultaneously differentiate and quantify the type and frequency of Brucella infections.
Materials and Methods
In this study, the 267 patients in our cohort had been admitted to the hospital, suspected of brucellosis based on clinical assessment. The subjects were entered into the study from August 1, 2009, through July 31, 2010. They had been referred to Imam Khomeini Hospital in Mianeh (East Azarbaijan province), located in northwest Iran.
Inclusion Criteria for Patients Suspected of Having Brucellosis
All patients suspected to have brucellosis based on symptoms and who had positive results on their serological tests via standard tube agglutination (STA), ELISA, or PCR were diagnosed as having brucellosis. According to the recommendation of the Laboratory Affairs Office of Iran, a titer of 1:80 and higher, rather than 1:160 and higher, might be considered as a positive result for Brucella by tube agglutination testing because of the confirmation of the former ratio in several Iranian brucellosis reports. 13 Tube agglutination testing was carried out using the Pasteurprotocol kit (Iranian Institute for Health Sciences Research Co, Tehran). ELISAs for measuring IgG and IgM antibodies used a 10 U/mL cut-off according to the manufacturer's protocol (Immuno Biological Laboratories Co Ltd, Fujioka, Japan; the unit was defined therein for each enzyme). Cultures were not included in the study because most of the patients were being treated at the time that samples were collected.
Sampling
Brucella species are highly infectious. Therefore, all specimen manipulations were performed in a protective hood that provided containment level 3 or higher. Blood specimens (5 mL) were collected by venipuncture in an ethylenediaminetetraacetic acid (EDTA) tube. One mL of blood from the sample was used for PCR 14 and the rest was used for tube agglutination and ELISA testing.
Tube Agglutination Methods and ELISA
Specimens were analyzed by the standard agglutination test (SAT), 2-mercaptoethanol (2ME), and the Coombs Wright test. The ELISA kit was provided by Immuno Biological Laboratories Co Ltd. Positive sera and normal saline were used as a quality control for the tests before use with patient specimens.
PCR
DNA was extracted using the High Pure PCR Template preparation kit (F. Hoffman-La Roche Ltd, Basel, Switzerland). The PCR protocol was based on IS 711 in the Brucella chromosome using the primers reported by Redkar et al ( Table 1) . 15 We used the conventional multiplex PCR approach, which detects B abortus and B melitensis by electrophoresis instead of using the real-time procedure. The PCR protocol was set up and optimized by B abortus strain 544 and B melitensis serotype 1 (strain 16M); unfortunately, we did not have access to the B suis strain. Therefore, B suis reverse primer was added to the mixture after optimizing the test for B abortus and B melitensis. 
Results
Optimization tests confirmed previously reported 14 concentrations of reaction mixture (Image 1). We changed amplification time in each segment of the PCR cycles and increased the annealing temperature from 58°C to The SAT method yielded positive results in 42 cases (38.2%), all of which yielded positive results on Coombs Wright testing as well. 2ME results were negative in 7 SAT-positive cases; overall, 14 patients had an SAT titer at least 4-fold higher than the 2ME titer. 50 ELISA-positive specimens displayed no reaction via SAT, 2ME, or Coombs Wright.
PCR results were positive in 51 cases; among them, 34 were positive by ELISA. Among the remaining 17 ELISAnegative samples, 1 was positive by SAT. Among the 59 specimens that were negative by PCR, 58 were positive by ELISA; the single ELISA-negative specimen in this group was positive by SAT ( Table 2) . 
PCR testing confirmed

Discussion
In this study, brucellosis was confirmed in 110 patients based on antibodies to Brucellae and the results of PCR testing. Among the applied methods we used for detecting Brucellae, the SAT displayed the lowest positivity rate. The low reliability of the SAT method has been previously reported. 8, 17, 18 The ELISA test, used to detect IgG and IgM, had the highest efficiency in diagnosis of brucellosis (83.6%) among all the methods we used, although it yielded negative results in 17 cases; in these cases, PCR and SAT results were positive in all of the SAT-negative cases and the ELISA results were positive in 16 of the 17 SAT-negative cases. These cases of PCR positivity with concurrent seronegative results via antibody methods need to be more thoroughly investigated. Culture-positive seronegative brucellosis has been previously reported. 19, 20 Overall, PCR detected Brucellae in 46.4% of the study subjects. The lower sensitivity of the PCR method compared with ELISA is consistent with the findings of other studies. 21, 22 One reason we observed lower sensitivity of PCR might be that we applied conventional multiplex PCR instead of the real-time method. Also, the causative agent in some of the brucellosis cases might be B suis; we had no positive control strain of this species to check the sensitivity of the test. In future work, genusspecific multiplex PCR should be applied and the results evaluated. Another potential reason for the lower sensitivity of the PCR method may be that brucellosis was wrongly diagnosed in some of our subjects at presentation. Some of us 8 previously reported ELISA, tube agglutination, and PCR testing results in patients admitted to Imam Khomeini Hospital. The conclusion was that the lower sensitivity observed for PCR (48.9%) resulted because all of the patients had been admitted with a documented medical history of incorrect antibiotic treatment. The seropositive specimens yielded negative results via PCR soon after the patients began appropriate treatment. In the present report, all of the subjects were outpatients but some may have had previous treatment with an incorrectly prescribed antibiotic before their arrival at the outpatient facility and enrollment in our study. Therefore, PCR may not be highly sensitive for chronic brucellosis or in patients who had previously been treated with incorrectly prescribed antibiotics. ELISA testing cannot confirm brucellosis because it yielded positive results in only 83.6% of the patients with brucellosis in our cohort.
Two studies have reported differentiation of Brucella species in Iran. In a report by Khosravi et al, 23 none of the examined specimens tested positive for B abortus. However, in 2011, Doosti et al 24 collected specimens from the provinces of Isfahan and Chaharmahal Va Bakhtiari and reported that, among 76 PCR-positive cases, 41 had tested positive for B abortus and 6 had tested positive for B melitensis. They reported that the frequency of B abortus was higher than B melitensis in Chaharmahal Va Bakhtiari, compared with Isfahan. Hence, the frequency of Brucella species can vary by region in Iran.
Brucellosis is an uncommon infectious disease. 25 The isolation rate for Brucella is high in countries in which it is endemic; serologic testing for the condition can often confirm the diagnosis in suspected patients. However, none of the available methods for diagnosis of brucellosis is highly sensitive. 8 Diagnostic laboratory methods based on serology are used in most countries because culture methods have low sensitivity and require special biosafety accommodations. Use of multiplex PCR that enables simultaneous detection of all species may be a strong alternative for confirming brucellosis.
Conclusion
ELISA yielded the highest sensitivity among the applied tests in our study, although it yielded negative results in several cases of brucellosis. By contrast, multiplex PCR can be a favorable method for diagnosis of the disease and identification of Brucella species. This method is especially helpful epidemiologically in patients who have 
